http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd
Development in wastewater treatment research and processes
innovative trends in removal of refractory pollutants from pharmaceutical wastewater
Development in Wastewater Treatment Research and Processes: Innovative Trends in Removal of Refractory Pollutants from Pharmaceutical Waste Water sorts out emerging and burning issues faced by the pharmaceutical industry, along with common effluent treatment plans.
Front Cover -- Development in Wastewater Treatment Research and Processes -- Development in Wastewater Treatment Research and Processes -- Contents -- Contributors -- 1 -- Pharmaceutical wastewater management: Physicochemical, chemical, and biological approaches -- 1. Introduction -- 2. Pharmaceutical compounds present in the wastewater -- 3. Physicochemical approach for the elimination of emerging contaminants -- 3.1 Coagulative precipitation -- 3.2 Electrocoagulation -- 3.3 Sedimentation -- 3.4 Floatation -- 3.5 Electrolysis -- 3.6 Adsorption -- 3.7 Membrane separation -- 4. Chemical approach for removing emerging contaminants -- 4.1 Advanced oxidation -- 4.2 Wet air oxidation (WAO) -- 4.3 Supercritical water oxidation (SCWO) -- 4.4 Electro-fenton reagent -- 4.5 Biological electro fenton (Bio-EF) -- 4.6 Photocatalytic oxidation -- 4.7 Ultrasound oxidation (UAO) -- 4.8 Electrochemical oxidation -- 4.9 Ozonation -- 4.10 Perozonation -- 4.11 Iron-carbon method -- 4.12 Chlorination -- 4.13 Flocculation -- 5. Biological treatment approach for the removal of emerging contaminants -- 5.1 Activated sludge process (ASP) -- 5.2 Sequence batch reactor (SBR) -- 5.3 Moving bed biofilm reactor (MBBR) -- 5.4 Membrane bioreactor (MBR) -- 5.5 Trickling filter (TF) -- 5.6 Anaerobic treatment system -- 5.6.1 Hybrid anaerobic+biological system -- 5.6.2 Hybrid anaerobic+chemical/physical systems -- 5.7 Hybrid biological-physical- treatment processes -- 5.8 Hybrid biological-physical-chemical treatment processes -- 6. Phyto-remediation approaches for pharmaceuticals wastewater treatment -- 7. Mycoremediation approaches for pharmaceuticals wastewater treatment -- 8. Phyco-remediation approaches for pharmaceutical wastewater treatment -- 9. Pharmaceuticals wastewater treatment during the COVID-19 pandemic.
10. Clustered regularly interspaced palindromic repeats (CRISPR) assisted bioremediation approach -- 11. Conclusion -- References -- 2 -- Applications of ultrafiltration, nanofiltration, and reverse osmosis in pharmaceutical wastewater treatment -- 1. Introduction -- 2. Membrane separation approaches -- 3. Removal of emerging pharmaceutical contaminants by nanofiltration membrane system -- 4. Removal of the emerging pharmaceutical contaminants by ultrafiltration membrane system -- 5. Removal of emerging contaminants by reverse osmosis membrane system -- 6. Conclusion -- References -- 3 -- Recent advancement in bioremediation of pharmaceutical wastewater -- 1. Introduction -- 2. Refractory pollutants -- 3. Pharmaceutical industry wastewater (PIWW) -- 4. Bioremediation -- 4.1 Bioadsorption -- 4.2 Bioaccumulation -- 4.3 Biodegradation -- 4.4 Photo-biodegradation -- 4.5 Volatilization -- 5. Microorganisms involved in bioremediation of PIWW -- 5.1 Bacterial bioremediation -- 5.2 Fungal bioremediation -- 5.3 Phycoremediation -- 5.4 Phytoremediation -- 6. Membrane bioreactors -- 7. Enzyme-driven bioremediation -- 8. Future perspective of bioremediation in PIWW treatment -- 9. Conclusions -- References -- 4 -- Hybrid membrane processes equipped with crystallization unit for a simultaneous recovery of freshwater and mine ... -- 1. Introduction -- 2. Principles of membrane crystallization -- 2.1 Module configurations in membrane distillation crystallization -- 2.1.1 DCMD -- 2.1.2 AGMD -- 2.1.3 VMD -- 2.1.4 SGMD -- 2.2 Process of crystallization and precipitation -- 2.3 Factors affecting crystallization -- 2.3.1 Temperature -- 2.3.2 Flowrate -- 2.3.3 Concentration of the feed solution -- 3. Membranes used in membrane crystallization -- 4. Fouling and wetting in membrane crystallization -- 5. Fouling and wetting mitigation strategies -- 5.1 Membrane modification.
5.2 Membrane cleaning -- 5.3 Pre-treatment processes -- 6. Application of membrane crystallization for the treatment of wastewater -- 7. Conclusion -- References -- 5 -- Advanced (nano)materials -- 1. Introduction -- 2. Green nanotechnology -- 3. Green nanomaterial preparation -- 3.1 Physical method -- 4. Chemical method -- 5. Biological method -- 6. Biosynthesis of NPs using microorganisms -- 6.1 Synthesis of nanoparticles using fungi -- 7. Synthesis of nanoparticles using yeast -- 8. Synthesis of nanoparticles using bacteria -- 9. Synthesis of nanoparticles using actinomycetes -- 10. Synthesis of nanoparticles using plant -- 11. Applications of green nanomaterials -- 12. Environmental cleanup -- 13. Nanoremediation -- 14. Nanomaterials as adsorbents for water treatment -- 15. Nanomaterials in photocatalysis -- 16. Copper oxide in photocatalysis -- 17. Nanosized iron oxides -- 18. Magnesium oxide NPs (MgO-NPs) -- 19. Nanocomposites in water treatment -- 20. Nanocomposite membrane -- 21. Magnetic nanocomposites -- 22. Chitosan NPs -- 23. Cellulose based nanoadsorbent -- 24. Dendrimer nanoadsorbent -- 25. Major problems in photocatalysis processes -- 26. Reusability of nanocomposites -- 27. Disinfection -- 28. Conclusion -- References -- 6 -- Removal of pharmaceutical contaminants from wastewater using activated sludge process -- 1. Introduction -- 1.1 Pharmaceutical manufacturing industries -- 1.2 Human and animal excretions -- 1.3 Hospital and clinic effluents -- 2. Major units of activated sludge process based wastewater treatment -- 2.1 Screening -- 2.2 Grit chamber -- 2.3 Primary settling tank -- 2.4 Aeration tank -- 2.5 Secondary clarifier -- 3. Removal of pharmaceutical contaminants by activated sludge process -- 3.1 Hydraulic retention time (HRT) -- 3.2 Sludge retention time (SRT) -- 3.3 Redox conditions and temperature.
4. Removal process in ASP for pharmaceuticals -- 4.1 Biodegradation -- 4.2 Sorption -- 5. Techniques to enhance elimination of pharmaceutical in ASP -- 5.1 Activated carbon insertion -- 5.2 Hybridization with ASP -- 6. Conclusion -- References -- 7 -- Bacteria mediated cadmium removal for wastewater treatment -- 1. Introduction -- 2. Cadmium toxicity -- 3. Conventional methods of cadmium removal -- 4. Bacteria mediated cadmium removal -- 5. Conclusions and future perspectives -- References -- 8 -- Oxidation and advanced oxidation processes in pharmaceutical wastewater treatment -- 1. Introduction -- 2. Organic contaminants in waste water -- 3. Oxidation processes -- 4. Advance oxidation processes -- 5. Principle and types of AOP -- 6. Mechanism of AOPs -- 7. Advanced AOPs catalyzed by hydrogen peroxide -- 8. AOPs using UV radiation -- 9. Strategies for efficient optimization of AOPs -- 10. Merits of AOPs -- 11. Limitations of AOPs -- 12. Studies on AOPs for waste water treatment -- 13. Conclusion and future trend -- References -- 9 -- Nanomaterials for the removal of pollutants from pharmaceutical wastewater -- 1. Introduction -- 2. Physio-chemical properties of pharmaceutical pollutants -- 3. Toxicological impact of pharmaceutical pollutants on ecosystem -- 4. Synthesis techniques of nanostructure materials -- 4.1 Chemical vapor deposition -- 4.2 Ball milling -- 4.3 Pyrolysis -- 4.4 Hydrothermal carbonization -- 4.5 Exfoliation -- 5. Mechanism behind the removal of contaminates by nanomaterials -- 6. Application of nanomaterials for the removal of pharmaceuticals -- 6.1 Carbon based nanomaterials -- 6.1.1 Carbon nanotubes -- 6.1.2 GO based nanomaterials -- 6.1.3 RGO based nanomaterials -- 6.2 Metal-based nanomaterials -- 7. Limitations -- 8. Conclusion and prospects -- References.
10 -- Bio nanotechnology: An emerging tools to remove refractory pollutant from pharmaceutical wastewater -- 1. Introduction -- 2. Methods for treatment of pharmaceutical waste water -- 3. Nanotechnology -- 4. Synthesis of nanoparticles -- 4.1 Nanoparticles produced by plants -- 5. Bacteria-generated nanoparticles -- 6. Yeast and fungal nanoparticles -- 7. Nanotechnology for bioremediation -- 8. Different nanomaterials and treatment of pharmaceutical waste water -- 9. Nanofilter membrane bioreactor -- 10. Nanoadsorbants -- 11. Nanocatalyst -- 12. Conclusion -- References -- 11 -- Bioremediation of pharmaceutical contaminants from wastewater by mushrooms -- 1. Introduction -- 2. Pharmaceutical residues -- 3. Wastewater treatment -- 4. Mushrooms in bioremediation of pharmaceutical contaminants from wastewater -- 4.1 Pleurotus sp. -- 4.2 Trametes versicolor -- 4.3 Phanerochaete chrysosporium -- 4.4 Agaricus bisporus and Lentinula edodes -- 5. Perspectives and conclusions -- References -- 12 -- Microbial bioremediation potentials for refractory pollutants removal from pharmaceutical wastewater -- 1. Introduction -- 2. Nature and origin of pharmaceutical wastes -- 3. Bioremediation in treatment of pharmaceutical wastes -- 3.1 Bacteria and actinomycetes in bioremediation -- 3.2 Ultrafiltration membrane biological reactor based on nitrifying bacteria -- 3.3 Fungal bioremediation -- 3.4 Microalgal bioremediation (phycoremediation) -- 3.5 Technologies used to improve microbial bioremediation -- 4. Future prospects and conclusion -- References -- 13 -- Innovative technologies for emerging issues in pharmaceuticals -- 1. Introduction -- 2. State of the art on the occurrence of pharmaceuticals all over the world -- 3. New emerging technologies for the removal of pharmaceuticals from the environment.
edited by Susana Rodriguez-Couto, Maulin P. Shah.